Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders
Laura Toma1, Mariana Deleanu1, Gabriela Maria Sanda1
1Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8 B.P. Haşdeu Street, 050568 Bucharest, Romania.
Phytosome formulations enhance the therapeutic benefits of bioactive compounds for metabolic disorders by improving bioavailability and solubility. This innovative delivery system offers a promising complementary therapy for managing these widespread health conditions.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Delivery Systems
Background:
- Metabolic disorders (MDs) like dyslipidemia, NAFLD, diabetes, obesity, and cardiovascular diseases pose significant health risks.
- Bioactive compounds (polyphenols, flavonoids, alkaloids, triterpenes) show therapeutic potential but suffer from low oral bioavailability, poor solubility, and rapid metabolism.
- These limitations hinder the efficacy of natural compounds in treating MDs.
Purpose of the Study:
- To review scientific evidence on the enhanced therapeutic benefits of phytosome-formulated bioactive compounds compared to free compounds.
- To explore the preparation, characterization, and bioavailability of phytosomes.
- To highlight commercially available phytosomes for alleviating MDs.
Main Methods:
- Literature review of scientific evidence on phytosome technology and its application in metabolic disorders.
- Analysis of studies comparing phytosome formulations with free bioactive compounds.
- Compilation of data on phytosome preparation, characterization, and bioavailability.
Main Results:
- Phytosome formulation significantly enhances the bioavailability and therapeutic efficacy of various bioactive compounds.
- Improved solubility and stability of compounds within phytosomes facilitate better absorption and cellular penetration.
- Evidence supports the use of phytosomes in ameliorating risk factors and treating established MDs.
Conclusions:
- Phytosomes represent an innovative and effective drug delivery system for bioactive compounds targeting metabolic disorders.
- This formulation strategy overcomes the limitations of conventional delivery, offering improved therapeutic outcomes.
- Phytosomes show potential as a complementary therapy to conventional treatments for MDs, improving patient health and quality of life.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
09:51One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
Related Concept Videos
Drug Metabolism: Phase II Reactions
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Drug Biotransformation: Overview
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Lysosomes
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
